IP Library Granted Patent US 10,980,786
Granted Patent B2
US 10,980,786 · App. 15/879,660 · Granted Apr 20, 2021

Maternal vitamin B6 administration for the prevention of increased adiposity, overweight or obesity in the offspring

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,980,786
App. No.
15/879,660
Granted
Apr 20, 2021
Kind
B2
Abstract

The present invention generally relates to the early prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in infants or children. For example, the present invention relates to the prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in infants or children through appropriate nutrition for women desiring to get pregnant and/or during pregnancy and/or lactation. Embodiments of the present invention relate to the Vitamin B6 for use in the prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in the offspring, wherein the vitamin B6 is administered to women desiring to get pregnant and/or to the mother during pregnancy and/or lactation and to maternal food compositions that can be used for this purpose.

Claims (14)

1. A method of reducing the likelihood of developing overweight and/or excessive build-up of abdominal and/or visceral fat mass in adulthood of an offspring of a mother having a vitamin B6 intake of below 1.9 mg/day or having a vitamin B6 serum level of less than 20 nmol/l, the method comprising administering a composition in a daily dose comprising Vitamin B6 in an amount of 2.5-60 mg Vitamin B6/day to the mother at a time period selected from the group consisting of before pregnancy, during pregnancy, during lactation, and combinations thereof, wherein the composition further comprises a component selected from the group consisting of probiotic bacteria, folic acid, calcium, iron, arachidonic acid (ARA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and mixtures thereof.

2. The method of claim 1 , wherein the composition is in the form of a maternal food composition.

3. The method in accordance with claim 2 , wherein the maternal food composition is selected from the group consisting of a powdered nutritional composition to be reconstituted in milk or water, a nutritional formula, a cereal based-product, a drink, a bar, a nutritional supplement, a nutraceutical, a yogurt, a milk-derived product, a food sprinkler, a pill and a tablet.

4. The method of claim 1 , wherein the composition is administered to the mother for at least 4 consecutive weeks before pregnancy, during pregnancy, and/or during lactation.

5. A method of reducing the likelihood of developing overweight and/or excessive build-up of abdominal and/or visceral fat mass in adulthood of an offspring of a mother having a vitamin B6 intake of below 1.9 mg/day or having a vitamin B6 serum level of less than 20 nmol/l, the method comprising administering a composition in a daily dose comprising Vitamin B6 in an amount of 2.5-60 mg Vitamin B6/day to the mother at a time period selected from the group consisting of before pregnancy, during pregnancy, during lactation, and combinations thereof, wherein the composition is provided from a source selected from the group consisting of fish, meat, egg, crude rice, crude wheat, potatoes, chickpeas, peas, beans, squash, fruit, dried herbs, dried spices, nuts, seeds, extracts thereof, and combinations thereof.

6. A method of reducing the likelihood of developing overweight and/or excessive build-up of abdominal and/or visceral fat mass in adulthood of an offspring of a mother having a vitamin B6 intake of below 1.9 mg/day or having a vitamin B6 serum level of less than 20 nmol/l, the method comprising administering a composition in a daily dose comprising Vitamin B6 in an amount of 2.5-60 mg Vitamin B6/day to the mother at a time period selected from the group consisting of before pregnancy, during pregnancy, during lactation, and combinations thereof, wherein the mother is a multiparous, overweight and/or obese mother and/or a mother suffering from metabolic syndrome.

7. A method of reducing the likelihood of developing overweight and/or excessive build-up of abdominal and/or visceral fat mass in adulthood of an offspring of a mother having a vitamin B6 intake of below 1.9 mg/day or having a vitamin B6 serum level of less than 20 nmol/l, the method comprising administering a composition in a daily dose comprising Vitamin B 6 in an amount of 2.5-60 mg Vitamin B6/day to the mother at a time period selected from the group consisting of before pregnancy, during pregnancy, during lactation, and combinations thereof, wherein the composition further comprises a component selected from the group consisting of a protein source, a carbohydrate source, a lipid source, lecithin, bulking agents, and mixtures thereof.

8. The method of claim 1 , wherein the composition is administered in a daily dose comprising vitamin B6 in an amount of 2.5-40 mg Vitamin B6/day.

9. The method of claim 1 , wherein the composition is administered in a frequency selected from the group consisting of two times a day, daily, every two days, weekly, and combinations thereof.

10. A method of reducing the likelihood of developing overweight and/or excessive build-up of abdominal and/or visceral fat mass in adulthood of an offspring of a mother having a vitamin B6 intake of below 1.9 mg/day or having a vitamin B6 serum level of less than 20 nmol/l, the method comprising administering a composition in a daily dose comprising Vitamin B6 in an amount of 2.5-60 mg Vitamin B6/day wherein the composition is administered to the mother daily for at least 36 consecutive weeks during pregnancy and/or during lactation.

11. The method of claim 1 , wherein the composition is administered in a daily dose comprising Vitamin B6 in an amount of 2.6-40 mg Vitamin B6/day.

12. A method of reducing the likelihood of developing overweight and/or excessive build-up of abdominal and/or visceral fat mass in adulthood of an offspring of a mother having a vitamin B6 intake of below 1.9 mg/day or having a vitamin B6 serum level of less than 20 nmol/l, the method comprising administering a composition in a daily dose comprising Vitamin B6 in an amount of 2.5-60 mg Vitamin B6/day to the mother before pregnancy.

13. The method of claim 12 , wherein the composition is administered to the mother during one, two, or four months preceding the pregnancy.

14. A method of reducing the likelihood of developing overweight and/or excessive build-up of abdominal and/or visceral fat mass in adulthood of an offspring of a mother having a vitamin B6 intake of below 1.9 mg/day or having a vitamin B6 serum level of less than 20 nmol/l, the method comprising administering a composition in a daily dose comprising Vitamin B6 in an amount of 2.5-60 mg Vitamin B 6 /day to the mother at a time period selected from the group consisting of before pregnancy, during pregnancy, during lactation, and combinations thereof, wherein the Vitamin B6 is provided as a sustained release formulation.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2018
From: COOPER, CYRUS; GODFREY, KEITH MALCOM; GLUCKMAN, PETER DAVID; MACE, CATHERINE; ZOLEZZI, IRMA SILVA
To: NESTEC S.A.
Reel/Frame 047201/0171 →